Media » MPP Symposium at the 48th Union World Conference on Lung Health

MPP Symposium at the 48th Union World Conference on Lung Health

The MPP will convene a symposium at the 48th Union World Conference on Lung Health taking place from 11-14 October in Guadalajara, Mexico:

The role of public health licences to accelerate development and access to TB drugs
Friday 13 October from 14h00-15h30
Hall 2 – Events Ballroom

The agreement in January 2017 between the Medicines Patent Pool (MPP) and Johns Hopkins University for sutezolid was MPP’s first intellectual property licence for TB. This session will review the experience of MPP’s first TB licence and the importance of public health-oriented licences to ensure, not only the development of affordable products, but also to facilitate the clinical development of products further back in the clinical pipeline. It will also discuss what else needs to happen to facilitate and promote the development of new treatments for TB while ensuring affordability.


14:00 – 14:15: The process of licencing TB drugs: experience of the medicines patent pool in sutezolid license – Chan Park, Switzerland

14:15 – 14:30: The importance of public health orientated licences to ensure academic research benefits all – Merith Basey, United States of America

14:30 – 14:45: Utilizing public health oriented licenses as a tool to facilitate the development of new regimens – Melvin Spigelman, United States of America

14:45 – 15:00: The importance of data pooling in addition to IP pooling – Debra Hanna, United States of America

15:00 – 15:15: The role of IP and data pooling to promote access for trials and beyond – Grania Brigden, Switzerland

15:15 – 15:30: Discussion

More information on the programme

This website uses cookies to ensure you get the best experience on our website. Learn More